Theratechnologies Inc T.TH

S&P Biotech Index Up 6.2% This Week

[SPCEO1]

THTX up 0.3%. That is obviously not good. Hopefully, a new communications effort by new staff will sort out how to get THTX on the biotech radar so that it participates in moves like this in the future. Right now, however, it is a backwater biotech stock that gets no respect.

[Bucknelly21]

Always participating on the downside never on the up...

[SPCEO1]

THTX is up 40% this year, so I am not sure where you are getting that take. For the last month or so, the stock is not participating on the upside or the downside - it is just stuck at $3.50. And that is very odd.

[longterm56]

The sad truth is that the market is treating us like CYDY ... they also post news with no reaction. I'm not saying we are anything like them, just that the market is treating us similarly. Very sad -LT

[SPCEO1]

CYDY is down 80% this year and THTX is up 40%, so this too is a bad take. But I would not mind having CYDY's current market cap!

[qwerty22]

It's just the worst comparable. What they report makes no sense, it deserves to be ignored. Their NASH "data" is meaningless, 5 open label patients???. Their cancer data is a dog's dinner. It's clearly cherry-picked, the number of patients reported is going down rather than up even as the number of trials they are picking those patients from is going up. They are reporting